Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Net Income (2020 - 2026)

Barinthus Biotherapeutics filings provide 7 years of Net Income readings, the most recent being -$5.5 million for Q1 2026.

  • On a quarterly basis, Net Income rose 71.85% to -$5.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$52.3 million, a 19.88% increase, with the full-year FY2025 number at -$66.5 million, down 8.62% from a year prior.
  • Net Income hit -$5.5 million in Q1 2026 for Barinthus Biotherapeutics, up from -$11.1 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $15.7 million in Q2 2022 to a low of -$23.8 million in Q2 2023.
  • Median Net Income over the past 5 years was -$15.5 million (2024), compared with a mean of -$11.8 million.
  • Biggest five-year swings in Net Income: surged 248.69% in 2022 and later crashed 807.96% in 2023.
  • Barinthus Biotherapeutics' Net Income stood at -$21.2 million in 2022, then rose by 18.3% to -$17.3 million in 2023, then dropped by 19.09% to -$20.6 million in 2024, then soared by 46.08% to -$11.1 million in 2025, then skyrocketed by 50.16% to -$5.5 million in 2026.
  • The last three reported values for Net Income were -$5.5 million (Q1 2026), -$11.1 million (Q4 2025), and -$14.6 million (Q3 2025) per Business Quant data.